Literature DB >> 31135065

A pericyte-glia scarring develops at the leaky capillaries in the hippocampus during seizure activity.

Wendy Klement1, Marine Blaquiere1, Emma Zub1, Frederic deBock1, Fabien Boux2, Emmanuel Barbier2, Etienne Audinat1, Mireille Lerner-Natoli1, Nicola Marchi1.   

Abstract

OBJECTIVE: Inflammatory cerebrovascular damage occurs in epilepsy. Here, we tested the hypothesis that a pericyte-glia scar forms around the outer wall of hippocampal capillaries in a model of temporal lobe epilepsy associated with hippocampal sclerosis. We studied the participation of stromal cells expressing platelet-derived growth factor receptor beta (PDGFRβ) and extracellular matrix modifications to the perivascular scar during epileptogenesis.
METHODS: We used NG2DsRed/C57BL6 mice and induced status epilepticus (SE) followed by epileptogenesis and spontaneous recurrent seizures (SRS) by means of unilateral intrahippocampal injection of kainic acid (KA). For pharmacological assessment, we used organotypic hippocampal cultures (OHCs) where ictal electrographic activity was elicited by KA or bicuculline.
RESULTS: NG2DsRed pericytes, GFAP astroglia, and IBA1 microglia are reactive and converge to form a pericapillary multicellular scar in the CA hippocampal regions during epileptogenesis and at SRS. The capillaries are leaky as indicated by fluorescein entering the parenchyma from the peripheral blood. Concomitantly, PDGFRβ transcript and protein levels were significantly increased. Within the regional scar, a fibrotic-like PDGFRβ mesh developed around the capillaries, peaking at 1 week post-SE and regressing, but not resolving, at SRS. Abnormal distribution or accumulation of extracellular matrix collagens III/IV occurred in the CA regions during seizure progression. PDGFRβ/DAPI cells were in direct contact with or adjacent to the damaged NG2DsRed pericytes at the capillary interface, consistent with the notion of stromal cell reactivity or fibroblast formation. Inducing electrographic activity in OHCs was sufficient to augment PDGFRβ reactivity around the capillaries. The latter effect was pharmacologically mimicked by treating OHCs with the PDGFRβ agonist PDGF-BB and it was diminished by the PDGFRβ inhibitor imatinib. SIGNIFICANCE: The reported multicellular activation and scar are traits of perivascular inflammation and hippocampal sclerosis in experimental epilepsy, with an implication for neurovascular dysfunction. Modulation of PDGFRβ could be exploited to target inflammation in this chronic disease setting. Wiley Periodicals, Inc.
© 2019 International League Against Epilepsy.

Entities:  

Keywords:  blood-brain barrier; extracellular matrix; glia; inflammation; pericytes; perivascular scar; stromal cells

Mesh:

Substances:

Year:  2019        PMID: 31135065     DOI: 10.1111/epi.16019

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

1.  Microglial depletion aggravates the severity of acute and chronic seizures in mice.

Authors:  Wenning Wu; Yujiao Li; Yujia Wei; Dale B Bosco; Manling Xie; Ming-Gao Zhao; Jason R Richardson; Long-Jun Wu
Journal:  Brain Behav Immun       Date:  2020-07-02       Impact factor: 7.217

Review 2.  Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options.

Authors:  Wolfgang Löscher; Heidrun Potschka; Sanjay M Sisodiya; Annamaria Vezzani
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

3.  Temporal dynamics of cells expressing NG2 and platelet-derived growth factor receptor-β in the fibrotic scar formation after 3-nitropropionic acid-induced acute brain injury.

Authors:  Tae-Ryong Riew; Xuyan Jin; Soojin Kim; Hong Lim Kim; Mun-Yong Lee
Journal:  Cell Tissue Res       Date:  2021-04-17       Impact factor: 5.249

Review 4.  Links between Immune Cells from the Periphery and the Brain in the Pathogenesis of Epilepsy: A Narrative Review.

Authors:  Gaku Yamanaka; Shinichiro Morichi; Tomoko Takamatsu; Yusuke Watanabe; Shinji Suzuki; Yu Ishida; Shingo Oana; Takashi Yamazaki; Fuyuko Takata; Hisashi Kawashima
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

5.  Simvastatin, edaravone and dexamethasone protect against kainate-induced brain endothelial cell damage.

Authors:  Lilla Barna; Fruzsina R Walter; András Harazin; Alexandra Bocsik; András Kincses; Vilmos Tubak; Katalin Jósvay; Ágnes Zvara; Patricia Campos-Bedolla; Mária A Deli
Journal:  Fluids Barriers CNS       Date:  2020-02-10

Review 6.  Neuroinflammatory In Vitro Cell Culture Models and the Potential Applications for Neurological Disorders.

Authors:  Ye Peng; Shifeng Chu; Yantao Yang; Zhao Zhang; Zongran Pang; Naihong Chen
Journal:  Front Pharmacol       Date:  2021-04-23       Impact factor: 5.810

Review 7.  Clearance Systems in the Brain, From Structure to Function.

Authors:  Jiachen Liu; Yunzhi Guo; Chengyue Zhang; Yang Zeng; Yongqi Luo; Gaiqing Wang
Journal:  Front Cell Neurosci       Date:  2022-01-31       Impact factor: 5.505

8.  Characterisation of PDGF-BB:PDGFRβ signalling pathways in human brain pericytes: evidence of disruption in Alzheimer's disease.

Authors:  Leon C D Smyth; Blake Highet; Deidre Jansson; Jane Wu; Justin Rustenhoven; Miranda Aalderink; Adelie Tan; Susan Li; Rebecca Johnson; Natacha Coppieters; Renee Handley; Pritika Narayan; Malvindar K Singh-Bains; Patrick Schweder; Clinton Turner; Edward W Mee; Peter Heppner; Jason Correia; Thomas I-H Park; Maurice A Curtis; Richard L M Faull; Mike Dragunow
Journal:  Commun Biol       Date:  2022-03-17

9.  Peripheral Blood and Salivary Biomarkers of Blood-Brain Barrier Permeability and Neuronal Damage: Clinical and Applied Concepts.

Authors:  Damir Janigro; Damian M Bailey; Sylvain Lehmann; Jerome Badaut; Robin O'Flynn; Christophe Hirtz; Nicola Marchi
Journal:  Front Neurol       Date:  2021-02-04       Impact factor: 4.003

Review 10.  The Neuroinflammatory Role of Pericytes in Epilepsy.

Authors:  Gaku Yamanaka; Fuyuko Takata; Yasufumi Kataoka; Kanako Kanou; Shinichiro Morichi; Shinya Dohgu; Hisashi Kawashima
Journal:  Biomedicines       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.